98%
921
2 minutes
20
Background: Osteoporosis and obesity are both major global public health problems. Observational studies have found that osteoporosis might be related to obesity. Mendelian randomization (MR) analysis could overcome the limitations of observational studies in assessing causal relationships.
Objective: This study aims to evaluate the causal potential relationship between obesity-related indicators and osteoporosis by using a two-sample MR analysis and to identify potential mediators.
Method: A total of 53 obesity-related indicators, 3,282 plasma protein lists, and 452 blood metabolite lists were downloaded from the public data set as instrumental variables, and the osteoporosis GWAS data of the MRC IEU Open GWAS database was used as the outcome indicators. Using two-sample univariate MR, multivariate MR, and intermediate MR, the causal relationship and mediating factors between obesity-related indicators and osteoporosis were identified.
Results: The IVW model results show that 31 obesity-related indicators may have a significant causal relationship with osteoporosis ( < 0.05), except for waist circumference (id: Ieu-a-71, OR = 1.00566); the remaining 30 indicators could reduce the risk of osteoporosis (OR: 0.983-0.996). A total of 25 plasma protein indicators may have a significant causal relationship with osteoporosis ( < 0.05), and 10 of them, such as ANKED46, KLRF1, and LPO, CA9 may have a protective effect on osteoporosis (OR: 0.996-0.999), while the other 15 such as ATP1B1, zinc finger protein 175, could increase the risk of osteoporosis (OR: 1.001-1.004). For blood metabolite indicators, except for alanine (id: Met a-469, OR: 1.071), the other six blood metabolite indicators including uridine and 1-linoleoylglycerophosphoethanolaminecan may have a protective effect on osteoporosis ( < 0.05, OR: 0.961-0.992). The direction of causal relationship of MR is all correct; the heterogeneity is all not significant and not affected by horizontal pleiotropy. Using multivariate and mediated MR analysis, it was found that the protective effect of obesity-related indicators against osteoporosis may be mediated by histone-lysine N-methyltransferase in plasma proteins and alanine in blood metabolites.
Conclusion: Obesity may confer a protective effect against osteoporosis, potentially mediated by EHMT2 in plasma proteins and alanine in blood metabolites. Further empirical research is required to fully elucidate the mechanisms behind the influence of obesity on osteoporosis. Interventions on obesity-related factors to reduce the risk of osteoporosis while controlling other adverse effects associated with obesity may require further research.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11876022 | PMC |
http://dx.doi.org/10.3389/fendo.2025.1435295 | DOI Listing |
Zhong Nan Da Xue Xue Bao Yi Xue Ban
May 2025
Department of Epidemiology and Health Statistics, Xiangya School of Public Health, Central South University, Changsha 410013, China.
Objectives: Intracranial aneurysm (IA) has an insidious onset, and once ruptured, it carries high rates of mortality and disability. Cardiometabolic factors may be associated with the formation and rupture of IA. This study aims to summarize the application of Mendelian randomization (MR) methods in research on cardiometabolic factors and IA, providing insights for further elucidation of IA etiology and pathogenesis.
View Article and Find Full Text PDFDiabetes Metab Res Rev
September 2025
Interdisciplinary Department of Medicine, School of Medicine, University of Bari 'Aldo Moro', Bari, Italy.
Overweight and obesity represent common chronic metabolic disorders in the general population, and observed trends describe a substantial growth in the prevalence of weight excess also among individuals with type 1 diabetes (T1D), the so-called 'lean phenotype' of diabetes. The sharp rise of weight excess and obesity-related cardio-nephron-metabolic burdens observed in T2D is expected to produce similar consequences in T1D, leading to the urgent need to endorse therapeutic protocols as in most parts of the World no adjunctive treatments are approved for T1D, making weight excess management challenging in these individuals. The notable results shown by newer glucagon-like peptide 1 receptor agonists (GLP-1RAs) and emerging dual agonists, especially while managing cardio-metabolic burdens, in T2D have encouraged fervent anecdotal and non-anecdotal research also in T1D, indicating that non-insulin injective agents can be effective and safe.
View Article and Find Full Text PDFExp Gerontol
September 2025
Department of General Practice, Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, 710032, China. Electronic address:
Background: The triglyceride-glucose (TyG) index and its obesity-related derivatives have emerged as surrogate markers for metabolic dysfunction. This study aimed to explore their associations with glaucoma in hypertensive adults in the U.S.
View Article and Find Full Text PDFMol Metab
September 2025
Department of Medicine, Division of Endocrinology & Metabolism, University of California San Diego; La Jolla, California, USA. Electronic address:
Obesity is intricately linked to various metabolic diseases; however, some individuals maintain metabolic health despite being classified as obese. A critical factor underlying this paradox is the expansion of white adipose tissue (WAT), which can occur through two mechanisms: hypertrophy (the enlargement of existing fat cells) and hyperplasia (the formation of new fat cells from adipocyte precursor cells, or APCs). Hyperplasia is regarded as a healthier mode of WAT expansion, as it tends to reduce inflammation and protect against insulin resistance.
View Article and Find Full Text PDFFood Sci Nutr
September 2025
Department of Nutrition, Graduate School of Human Life and Ecology Osaka Metropolitan University Osaka Japan.
(black cumin seed) has traditionally been valued for its medicinal properties. This study explored its potential in addressing obesity-related conditions by assessing its anti-adipogenic and lipid-lowering effects. Black cumin seed extract showed high phenolic (35.
View Article and Find Full Text PDF